|
OMIM |
Link |
Information gain |
01 |
|
folic acid, transport defect involving
|
[NCBI]
|
0.01585
|
|
|
TYMS
|
[NCBI]
|
0.00233325
|
|
|
anencephaly
|
[NCBI]
|
0.00154489
|
|
|
DHFR
|
[NCBI]
|
0.00135451
|
|
|
d-glyceric acidemia
|
[NCBI]
|
0.00124792
|
|
|
methylmalonic aciduria and homocystinuria, cbld type
|
[NCBI]
|
0.00124792
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
0.00120519
|
|
|
formiminotransferase deficiency
|
[NCBI]
|
0.000927268
|
|
|
homocysteinemia
|
[NCBI]
|
0.000875861
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000802705
|
|
|
FPGS
|
[NCBI]
|
0.000611948
|
|
|
MTHFR
|
[NCBI]
|
0.000567724
|
|
|
MTR
|
[NCBI]
|
0.000505133
|
|
|
CRC
|
[NCBI]
|
0.000491851
|
|
|
CPI
|
[NCBI]
|
0.000318634
|
|
|
homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cble complementation type
|
[NCBI]
|
0.000293083
|
|
|
FOLR1
|
[NCBI]
|
0.000227951
|
|
|
neural tube defects
|
[NCBI]
|
0.000213932
|
|
|
fragile site 2q11
|
[NCBI]
|
0.00020466
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
0.000200085
|
|
|
SLC19A1
|
[NCBI]
|
0.00018257
|
|
|
MTRR
|
[NCBI]
|
0.000178593
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.000167503
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
0.000159522
|
|
|
SLE
|
[NCBI]
|
0.000153726
|
|
|
folate level in erythrocytes
|
[NCBI]
|
0.000133794
|
|
|
epilepsy with bilateral occipital calcifications
|
[NCBI]
|
0.000133794
|
|
|
fragile site 17p12
|
[NCBI]
|
0.000133794
|
|
|
fragile site: additional types
|
[NCBI]
|
0.000133794
|
|
|
fragile site 9q32
|
[NCBI]
|
0.000133794
|
|
|
homocystinuria
|
[NCBI]
|
0.00012482
|
|
|
AD
|
[NCBI]
|
0.00011274
|
|
|
GNMT
|
[NCBI]
|
9.12259e-05
|
|
|
mental retardation, fra12a type
|
[NCBI]
|
9.04069e-05
|
|
|
MDD
|
[NCBI]
|
8.71737e-05
|
|
|
SLC25A32
|
[NCBI]
|
8.65588e-05
|
|
|
GRHL3
|
[NCBI]
|
7.62613e-05
|
|
|
MTHFD1
|
[NCBI]
|
6.33192e-05
|
|
|
peroxidase and phospholipid deficiency in eosinophils
|
[NCBI]
|
6.27637e-05
|
|
|
EBS2
|
[NCBI]
|
6.27637e-05
|
|
|
l-2-hydroxyglutaric aciduria
|
[NCBI]
|
6.02906e-05
|
|
|
FOLR2
|
[NCBI]
|
5.94775e-05
|
|
|
FOLR3
|
[NCBI]
|
5.94775e-05
|
|
|
TNF
|
[NCBI]
|
5.71588e-05
|
|
|
CD
|
[NCBI]
|
5.52971e-05
|
|
|
IFD
|
[NCBI]
|
5.42248e-05
|
|
|
VEGF
|
[NCBI]
|
5.22504e-05
|
|
|
RA
|
[NCBI]
|
5.07834e-05
|
|
|
SLC46A1
|
[NCBI]
|
4.9276e-05
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
4.68751e-05
|
|
|
TRMA
|
[NCBI]
|
4.56726e-05
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
4.45369e-05
|
|
|
LRP6
|
[NCBI]
|
4.08221e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
4.05409e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
3.88077e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
3.85402e-05
|
|
|
CSID
|
[NCBI]
|
3.79952e-05
|
|
|
GGH
|
[NCBI]
|
3.68412e-05
|
|
|
FTHFD
|
[NCBI]
|
3.48409e-05
|
|
|
BHMT
|
[NCBI]
|
3.39658e-05
|
|
|
NGFB
|
[NCBI]
|
3.38269e-05
|
|
|
EGF
|
[NCBI]
|
3.17166e-05
|
|
|
PTH
|
[NCBI]
|
3.06418e-05
|
|
|
GLY B+
|
[NCBI]
|
2.74253e-05
|
|
|
MTHFS
|
[NCBI]
|
2.74253e-05
|
|
|
PD
|
[NCBI]
|
2.69472e-05
|
|
|
PEMT
|
[NCBI]
|
2.62244e-05
|
|
|
FOLH1
|
[NCBI]
|
2.57642e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
2.55418e-05
|
|
|
TCF17
|
[NCBI]
|
2.46314e-05
|
|
|
PTER
|
[NCBI]
|
2.46314e-05
|
|
|
CART1
|
[NCBI]
|
2.46314e-05
|
|
|
XDH
|
[NCBI]
|
2.43651e-05
|
|
|
SCZD
|
[NCBI]
|
2.23319e-05
|
|
|
PCBP1
|
[NCBI]
|
2.14747e-05
|
|
|
HNRNPK
|
[NCBI]
|
2.14747e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.93201e-05
|
|
|
TH
|
[NCBI]
|
1.75268e-05
|
|
|
T
|
[NCBI]
|
1.75048e-05
|
|
|
CITED2
|
[NCBI]
|
1.75048e-05
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
1.65863e-05
|
|
|
PCBP2
|
[NCBI]
|
1.6497e-05
|
|
|
ANXA2
|
[NCBI]
|
1.56539e-05
|
|
|
DBA
|
[NCBI]
|
1.52934e-05
|
|
|
MAT1A
|
[NCBI]
|
1.46029e-05
|
|
|
DNMT1
|
[NCBI]
|
1.19675e-05
|
|
|
FTD
|
[NCBI]
|
1.19585e-05
|
|
|
FHIT
|
[NCBI]
|
1.14244e-05
|
|
|
COMT
|
[NCBI]
|
1.08967e-05
|
|
|
GPX1
|
[NCBI]
|
1.07964e-05
|
|
|
ACP1
|
[NCBI]
|
1.05106e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
1.03739e-05
|
|
|
KSS
|
[NCBI]
|
1.00316e-05
|
|
|
MTCYB
|
[NCBI]
|
9.5133e-06
|
|
|
AFP
|
[NCBI]
|
9.40128e-06
|
|
|
HS
|
[NCBI]
|
8.78694e-06
|
|
|
NAT1
|
[NCBI]
|
8.24478e-06
|
|
|
GFAP
|
[NCBI]
|
7.29935e-06
|
|
|
ACHE
|
[NCBI]
|
6.8483e-06
|
|
|
CHAT
|
[NCBI]
|
5.9867e-06
|
|
|
CCND1
|
[NCBI]
|
4.75047e-06
|
|
|
PC
|
[NCBI]
|
4.71458e-06
|
|
|
EGFR
|
[NCBI]
|
3.80726e-06
|
|
|
LEP
|
[NCBI]
|
3.54652e-06
|
|
|
EPO
|
[NCBI]
|
3.22322e-06
|
|
|
AGER
|
[NCBI]
|
3.21336e-06
|
|
|
HGF
|
[NCBI]
|
3.07668e-06
|
|
|
ABCG2
|
[NCBI]
|
2.99662e-06
|
|
|
APC
|
[NCBI]
|
2.7547e-06
|
|
|
ALB
|
[NCBI]
|
2.26677e-06
|
|
|
PYY
|
[NCBI]
|
2.03554e-06
|
|
|
amyloidosis vi
|
[NCBI]
|
1.8511e-06
|
|
|
G6PD
|
[NCBI]
|
1.61555e-06
|
|
|
F3
|
[NCBI]
|
1.50266e-06
|
|
|
PTHLH
|
[NCBI]
|
1.2658e-06
|
|
|
APOE
|
[NCBI]
|
9.16396e-07
|
|
|
GJA1
|
[NCBI]
|
8.05634e-07
|
|
|
HBB
|
[NCBI]
|
5.751e-07
|
|
|
APOB
|
[NCBI]
|
5.639e-07
|
|
|
CP
|
[NCBI]
|
5.19435e-07
|
|
|
temporal arteritis
|
[NCBI]
|
2.29656e-07
|
|
|
PCNA
|
[NCBI]
|
1.92159e-07
|
|
|
CAT
|
[NCBI]
|
1.0456e-07
|
|
|
TFPI
|
[NCBI]
|
1.80624e-09
|
|